Since sirtuin activity, brain-derived neurotrophic factor (BDNF) expression, and global DNA methylation levels significantly decrease in patients with PD or dementia, our group previously proposed the integration of these three epibiomarkers to improve NDD diagnostic accuracy [77]. This evidence concerns the gene BDNF and Parkinson disease.